LANXESS narrows full-year guidance range in a challenging market environment
EBITDA pre exceptionals in 2013: between EUR 710 million and EUR 760 million / Q3 with volume growth in all segments; continued pressure on prices
LANXESS commissions CO2 concentration unit at Newcastle site in South Africa
EUR 40 million investment supports future growth of sodium dichromate production / 25 percent reduction in CO2 emissions
LANXESS: 2013 to remain challenging
Q2 sales EUR 2.1 billion, down 12 percent / Q2 EBITDA pre exceptionals EUR 198 million, down 45 percent
LANXESS acquires Asian biocide specialist PCTS
Strengthening focus on megatrend urbanization / LANXESS expands leading position as biocide supplier in paints and coatings market
IR_LANXESS to build new pigment plant in China
Investment of EUR 55 million / 150 new jobs / Global pigment production network expanded
LANXESS signs new EUR 1.25 billion syndicated credit facility
The credit facility will serve as long-term liquidity and as a financial back-up for the company’s growth strategy.
IR_LANXESS places EUR 500 million bond
Ten year maturity / 2.625% per year coupon / Extension of debt maturity profile
IR_LANXESS confirms FY guidance amid challenging environment
Q3 sales EUR 2.2 billion, down 8% yr-on-yr / Q3 EBITDA pre EUR 255 million, down 18% / FY outlook: EBITDA pre growth expected at lower end of guided 5-10% range / Focus on flexible asset management and strict cost discipline